Jeffrey has made over 1 trades of the RTI Surgical stock since 2017, according to the Form 4 filled with the SEC. Most recently he bought 7,557,436 units of RTIX stock worth $4,987,908 on 28 February 2017.
The largest trade he's ever made was buying 7,557,436 units of RTI Surgical stock on 28 February 2017 worth over $4,987,908. On average, Jeffrey trades about 2,519,145 units every 0 days since 2017. As of 28 February 2017 he still owns at least 32,500,478 units of RTI Surgical stock.
You can see the complete history of Mr. Lightcap stock trades at the bottom of the page.
Jeffrey C. Lightcap is Independent Director of the Company. Mr. Lightcap joined the Board of Directors on March 8, 2019. Since mid-2006, Mr. Lightcap has served as a Senior Managing Director at HealthCor Partners Management, LP, a growth equity investor focused on late stage venture and early commercial stage healthcare companies in the diagnostic, therapeutic and med tech, sectors. From 1997 to mid-2006, Mr. Lightcap served as a Senior Managing Director at JLL Partners, a leading middle-market private equity firm. Prior to JLL Partners, from 1993 to 1997, Mr. Lightcap served as a Managing Director at Merrill Lynch & Co., Inc. Prior to joining Merrill Lynch, Mr. Lightcap was a Senior Vice President in the mergers and acquisitions group at Kidder, Peabody & Co. and briefly at Salomon Brothers. Mr. Lightcap received a B.E. in Mechanical Engineering from the State University of New York at Stony Brook in 1981 and in 1985 received an MBA from the University of Chicago. Mr. Lightcap currently also serves as Chairman of the Board of Directors at Corindus Vascular Robotics, Inc. (NYSE: CVRS), a precision vascular robotics company and serves as a director of the following companies: Heartflow Inc., a medical technology company redefining the way heart disease is diagnosed and treated; CareView Communications, Inc. (OTCQB: CRVW), a healthcare technology company; KellBenx, Inc., a prenatal diagnostic technology company; and Practice Partners in HealthCare, a privately-held company specializing in management and operation of ambulatory surgical centers. Mr. Lightcap’s experience navigating the reimbursement landscape and advancing access to medical devices with substantial clinical data and high-growth potential and his leadership skills exhibited throughout his career make him well-qualified to serve as one of the Company’s directors.
Jeffrey Lightcap is 60, he's been the Independent Director of RTI Surgical since 2019. There are 4 older and 6 younger executives at RTI Surgical. The oldest executive at RTI Surgical Holdings, Inc. is Thomas McEachin, 67, who is the Independent Director.
Jeffrey's mailing address filed with the SEC is 520 LAKE COOK ROAD, SUITE 315, DEERFIELD, IL, 60015.
Over the last 21 years, insiders at RTI Surgical have traded over $71,830 worth of RTI Surgical stock and bought 390,515 units worth $1,973,594 . The most active insiders traders include Jeffrey C Lightcap, Mark Stolper y Terry M. Rich. On average, RTI Surgical executives and independent directors trade stock every 138 days with the average trade being worth of $62,561. The most recent stock trade was executed by Jonathon M Singer on 12 December 2018, trading 50,000 units of RTIX stock currently worth $214,000.
RTI Surgical Holdings, Inc. engages in the provision of biologic, metal, and synthetic-based surgical implants. It offers implants in the following categories: extremities, orthobiologics, spine, sports medicine, and surgical specialties. The company was founded in February 1998 and is headquartered in Deerfield, IL.
RTI Surgical executives and other stock owners filed with the SEC include: